IP Library › Assignment 012651/0478
Patent Assignment
Reel/Frame 012651/0478

Assignment of Assignor's Interest

Recorded: 2002-02-25 Pages: 2
Assignors
JACKOWSKI, GEORGE
Executed: 2002-01-09
MARSHALL, JOHN
Executed: 2002-01-09
Assignee
SYN X PHARMA
6354 VISCOUNT ROAD, MISSISSAUGA, ONTARIO L4V 1H3, CANADA
Covered Property (1)
Complement C3 Precursor Biopolymer Markers Predictive of Type Ii Diabetes
Patent: 7,097,989 →
Application: 09/993,287 →
Publication: US 2006/0160232
Related Assignments (7)
Other recorded transfers of the patent in this record — the chain of ownership.
Security Agreement Jul 18, 2003
From: SYNX PHARMA INC.
To: CANADA TRUST COMPANY, THE
Reel/Frame 014242/0790 →
Security Interest Feb 12, 2004
From: SYNX PHARMA INC.
To: NANOGEN, INC.
Reel/Frame 014337/0010 →
Change of Name Jul 3, 2006
From: SYN X PHARMA INC.
To: NANOGEN POINT OF CARE INC.
Reel/Frame 017881/0585 →
Assignment of Assignor's Interest Aug 31, 2006
From: NANOGEN POINT OF CARE INC.
To: NANOGEN INC.
Reel/Frame 018223/0786 →
Assignment of Intellectual Property Security Agreement Apr 15, 2008
From: THE CANADA TRUST COMPANY
To: NANOGEN, INC.
Reel/Frame 020807/0247 →
Release of Security Interest Apr 17, 2008
From: NANOGEN POINT OF CARE, INC.
To: NANOGEN, INC.
Reel/Frame 020826/0087 →
Grant of Security Interest Jul 25, 2008
From: NANOGEN, INC.
To: PORTSIDE GROWTH & OPPORTUNITY FUND, AS COLLATERAL AGENT
Reel/Frame 021291/0605 →